Wolfgang Wick, Chair of the WR since 1 February 2023, has been a member of the body since 2021 and was Chairman of the WR Medical Committee since 2022.
Wick has been Medical Director of General Neurology since 2014 and holds a chair in neurology with a focus on neuro-oncology at Heidelberg University Hospital. He is the center spokesman for the Head Clinic based there, as well as department head for neuro-oncology at the German Cancer Research Center. Wick's research includes brain tumors, tumor immunology, biomarker development, imaging and stroke care.
Born in 1970, Wick studied medicine at the University of Bonn, where he also received his doctorate, at Harvard Medical School, Boston (USA), and at King's College London (UK).
After his habilitation at the Institute of Neuropathology at the University of Tübingen (2003), Wick became Deputy Medical Director of General Neurology at the University Hospital of Tübingen in 2006, then Medical Director of the Department of Neurooncology/NCT and Professor of Clinical Neurooncology at the University of Heidelberg in 2007.
Born in Bonn, he already looks back on experience in science policy: among other things, he has been a member of the Leopoldina - National Academy of Sciences since 2020 and was President of the European Association for Neurooncology (EANO) in 2016-2018.
Over the course of his career to date, Wick has received numerous honors, including the German Cancer Prize in 2015 and the Heinrich Pette Prize of the German Society of Neurology (DGN) in 2006 (now the Science Prize of the DGN).
In 2019, Wick was named to Clarivate Analytics' list of Highly Cited Researchers. The international award names researchers whose publications have been cited most frequently worldwide in their respective fields.